Motor and Non-Motor Symptoms in Parkinson's Disease: Effects on Quality of Life.

INTRODUCTION This study aimed to evaluate motor and non-motor symptoms in idiopathic Parkinson's disease (IPD) patients and to determine the self-reported influence of all existing symptoms on their quality of life (QoL). METHODS The sociodemographic and clinical characteristics, medical treatments, and Modified Hoehn and Yahr (mH&Y) scores of IPD patients without cognitive impairment were recorded. A survey questioning different motor and non-motor symptoms was administered to the patients. The patients were asked to rate their symptoms by number from the greatest influence to the least influence on their QoL. Subjects were divided into two groups: those suffering from IPD for ≤5 years (Group 1) and those suffering from IPD for >5 years (Group 2). These groups were compared in terms of sociodemographic and clinical characteristics, existing symptoms, and influences of these symptoms on their QoL. RESULTS There were 63 patients in Group 1 and 37 patients in Group 2. No statistically significant differences were detected between the groups with respect to sociodemographic characteristics or mH&Y scores. The most common motor symptoms in both of these groups were tremor and bradykinesia; meanwhile, the non-motor symptoms most frequently encountered in these groups were pain-cramps, constipation, and excessive daytime sleepiness (EDS). Again, while the symptoms that most greatly disturbed QoL in all patients were reported to be tremor and bradykinesia, the most disturbing non-motor symptom was frequent voiding/incontinence, which was a less common symptom. Pain-cramp, constipation, and EDS, which were the most frequent non-motor symptoms, were the symptoms that least disturbed QoL. CONCLUSION It is widely accepted that motor symptoms determine QoL in IPD. However, non-motor symptoms are seen during all phases of the disease. The impact of non-motor symptoms on the QoL of IPD patients remains substantial. Therefore, in addition to the well-known motor symptoms, non-motor symptoms, which may be overlooked during physical examination yet may profoundly impact QoL, should be questioned and treated appropriately to improve QoL in PD patients as much as possible.

[1]  Angelo Antonini,et al.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[2]  Paolo Barone,et al.  International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Lees,et al.  Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[4]  Angelo Antonini,et al.  Parkinson's disease: the non-motor issues. , 2011, Parkinsonism & related disorders.

[5]  J. Assmus,et al.  Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. , 2013, Parkinsonism & related disorders.

[6]  K. Chaudhuri,et al.  The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire , 2010, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Stiggelbout,et al.  A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[8]  N. Jetté,et al.  The prevalence of Parkinson's disease: A systematic review and meta‐analysis , 2014, Movement disorders : official journal of the Movement Disorder Society.

[9]  D. Aarsland,et al.  Risk of dementia in Parkinson’s disease , 2001, Neurology.

[10]  A. Lang,et al.  Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. , 2002, JAMA.

[11]  M. Kenrick,et al.  Sexual limitations in people living with Parkinson's disease , 2005 .

[12]  J. Borod,et al.  Cognitive and behavioral dysfunction in Parkinson’s disease: neurochemical and clinicopathological contributions , 2004, Journal of Neural Transmission.

[13]  D. Cella,et al.  Measuring quality of life in palliative care. , 1995, Seminars in oncology.

[14]  A M Stiggelbout,et al.  Patient-reported autonomic symptoms in Parkinson disease , 2007, Neurology.

[15]  H. Reichmann,et al.  Beyond tremor and rigidity: non-motor features of Parkinson’s disease , 2009, Journal of Neural Transmission.

[16]  C. N. Homann,et al.  Experience, competency, and education: Graduating neurology residents’ experience with tPA , 2001, Neurology.

[17]  L. Mackeigan,et al.  Overview of health-related quality-of-life measures. , 1992, American journal of hospital pharmacy.

[18]  O. Tysnes,et al.  Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild , 2011, Movement disorders : official journal of the Movement Disorder Society.

[19]  Weiguo Liu,et al.  A clinical survey of pain in Parkinson's disease in Eastern China , 2015, International Psychogeriatrics.

[20]  Anette Schrag,et al.  What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? , 2010, Movement disorders : official journal of the Movement Disorder Society.

[21]  E. Tolosa,et al.  Diagnosis and the premotor phase of Parkinson disease , 2009, Neurology.

[22]  J. Friedman,et al.  Fatigue in levodopa-naïve subjects with Parkinson disease , 2008, Neurology.

[23]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.

[24]  Y. Agid,et al.  Hallucinations, REM sleep, and Parkinson’s disease , 2000, Neurology.

[25]  W. Weiner,et al.  Sleep disorders and sleep effect in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.